|
Federal Workplace Drug Testing, Mandatory Guidelines Scientific Analysis to Include the Oral Fluid Specimen
|
Other
|
SAMHSA
|
NIDA
|
Develop and implement a controlled clinical laboratory protocol to administer morphine-containing poppy seeds and Vicks Vapo-Inhaler to healthy normal participants and collect and analyze blood, urine & oral fluid for d-, l-methamphetamine & d-, l-amphetamine and opiates.
|
|
FedTel: Cross-Federal work group on telehealth
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIBIB, NLM, OD/DPCPSI/OBSSR
|
The goal of this work group is to develop a coordinated view of what the Federal government is undertaking in telehealth, in an effort to identify possible collaboration mechanisms and share lessons learned across multiple agencies. Current topics of emphasis include Telehealth and HIT; Technology, Innovation and Standards; Public Education of Telehealth; and Access to Health Care.
|
|
Filovirus Animal Non-Clinical Group (FANG)
|
Other
|
CDC, FDA
|
NIAID
|
The Filovirus Animal Non-Clinical Group (FANG) focuses on the advanced development of Filovirus Medical Countermeasures (MCM), both vaccines and therapeutics. The FANG will focus on the product development tools and other interagency product development (PD) issues relevant to Food and Drug Administration approval of filovirus MCM. The Portfolio Advisory Committee (PAC), as a standing interagency working group, oversees the FANG. The FANG will develop strategies to address broadly applicable and interagency product development issues relevant to licensure of filovirus MCM. The FANG will develop consensus recommendations to facilitate standardization of reagents, methods, and procedures across multiple agencies and laboratories.
|
|
First National Centers for AIDS Research/APC ECHPP Conference (November 2012)
|
Meeting/ Workshop
|
OS
|
NIAID, NICHD, NIDA, NIMH
|
The meeting provided a forum for exchange of progress an administrative supplement awarded to the Centers for AIDS Research (CFARs) to conduct operational research funded with the local departments of health (DOHs) to address the National HIV/AIDS Strategy (NHAS). The meeting fostered collaboration among CFARs, DOHs and the federal government to help implement the NHAS.
|
|
Food Safety and Nutrition Working Group
|
Other
|
CDC, FDA, OS
|
NIDDK, NIEHS
|
The Food Safety and Nutrition Working Group (FSNWG) aims to highlight and promote awareness of an integrated approach to nutrition and food science in academia, and among nutritionists and food scientists; facilitate the alignment of research priorities to address food safety, food quality, and nutrition in single studies; and identify future research areas that can mesh food safety, food quality, and nutrition together.
|
|
Forum on Child and Family Statistics
|
Resource Development
|
ACF, AHRQ, CDC, HRSA, SAMHSA
|
NIMH, NICHD, NIDA
|
The Federal Interagency Forum on Child and Family Statistics, or the Forum, is a working group of Federal agencies that collect, analyze, and report data on issues related to children and families. The Forum''s signature report, America''s Children: Key National Indicators of Well-Being, provides annual updates on the well-being of children and families in the United States across a range of domains.
|
|
Functional Glycomics in HIV Vaccine Design
|
Meeting/ Workshop
|
FDA
|
NIAID, NCI, NIGMS
|
The purpose of this workshop was to explore new avenues for HIV vaccine discovery. Topics included the role and functions of the HIV envelope glycans in viral transmission and potential vulnerability, identification of glycans in induction and maturation of broadly neutralizing antibodies, new tools to characterize glycosylation patterns, and the role of glycans in immunoglobulin effector function.
|
|
Gastric cancer incidence trends by anatomic subsite
|
Research Initiative
|
CDC
|
NCI
|
Collaboration on a joint analysis of gastric cancer incidence data for 1976-2007 from the NCI Surveillance, Epidemiology, and End Results (SEER) Program and the CDC National Program of Cancer Registries.
|
|
Gastrointestinal Drugs Advisory Committee (GIDAC) of the Division of Gastroenterology and Inborn Errors Products of the Center for Drug Evaluation and Research (CDER) of the FDA
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
CC
|
Gastrointestinal Drugs Advisory Committee (GIDAC) provides advice and recommendations to the FDA on the need for and design of clinical development programs necessary to support approval of parenteral lipid emulsion products as nutrition support.
|
|
Genetic, functional, and epidemiologic studies of chronic hepatitis C
|
Research Initiative
|
FDA
|
NCI
|
Interdisciplinary studies to determine the molecular and immunological mechanisms of action of interferon lambda region genetic variants in HCV infection.
|